Adjuvant Hormonal Therapy for Early-Stage Breast Cancer, Surgical Oncology Clinics of North America, vol.19, issue.3, pp.639-647, 2010. ,
DOI : 10.1016/j.soc.2010.03.006
Adjuvant aromatase inhibitor therapy: Outcomes and safety, Cancer Treatment Reviews, vol.36, issue.3, pp.249-261 ,
DOI : 10.1016/j.ctrv.2009.12.010
Tamoxifen resistance by a conformational arrest of the estrogen receptor ?? after PKA activation in breast cancer, Cancer Cell, vol.5, issue.6, pp.597-605, 2004. ,
DOI : 10.1016/j.ccr.2004.05.016
Targeted therapies in breast cancer: Where are we now?, European Journal of Cancer, vol.44, issue.18, pp.2781-2790, 2008. ,
DOI : 10.1016/j.ejca.2008.09.026
Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function, Cancer Research, vol.68, issue.3, pp.68826-833, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-2707
ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective, Medicinal Research Reviews, vol.16, issue.1, pp.166-215 ,
DOI : 10.1002/med.20209
c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry, Molecular and Cellular Biology, vol.18, issue.8, pp.184499-4508, 1998. ,
DOI : 10.1128/MCB.18.8.4499
Auricchio F: PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells, EMBO J, issue.21, pp.206050-6059, 2001. ,
Mitogenic Activity of Estrogens in Human Breast Cancer Cells Does Not Rely on Direct Induction of Mitogen-Activated Protein Kinase/Extracellularly Regulated Kinase or Phosphatidylinositol 3-Kinase, Molecular Endocrinology, vol.18, issue.11, pp.182700-2713, 2004. ,
DOI : 10.1210/me.2003-0133
Mitogenic Signaling of Insulin-like Growth Factor I in MCF-7 Human Breast Cancer Cells Requires Phosphatidylinositol 3-Kinase and Is Independent of Mitogen-activated Protein Kinase, Journal of Biological Chemistry, vol.272, issue.49, pp.27231163-31171, 1997. ,
DOI : 10.1074/jbc.272.49.31163
Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell Cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1), J Biol Chem, issue.28, pp.27625823-25833, 2001. ,
Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling, Cancer Res, issue.14, pp.623985-3991, 2002. ,
Definition of Functionally Important Mechanistic Differences among Selective Estrogen Receptor Down-regulators, Cancer Research, vol.67, issue.19, pp.9549-9560, 2007. ,
DOI : 10.1158/0008-5472.CAN-07-1590
Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA, Nucleic Acids Research, vol.31, issue.2, pp.31670-682, 2003. ,
DOI : 10.1093/nar/gkg141
Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways, Proceedings of the National Academy of Sciences, vol.98, issue.1, pp.247-252, 2001. ,
DOI : 10.1073/pnas.98.1.247
PKB/Akt modulates TGF-?? signalling through a direct interaction with Smad3, Nature Cell Biology, vol.6, issue.4, pp.358-365, 2004. ,
DOI : 10.1038/ncb1113
Structure and cell cycle-regulated transcription of the human cyclin A gene., Proceedings of the National Academy of Sciences, vol.91, issue.12, pp.915490-5494, 1994. ,
DOI : 10.1073/pnas.91.12.5490
p21WAF1/CIP1 Selectively Controls the Transcriptional Activity of Estrogen Receptor ??, Molecular and Cellular Biology, vol.25, issue.6, pp.2419-2430, 2005. ,
DOI : 10.1128/MCB.25.6.2419-2430.2005
Akt interacts directly with Smad3 to regulate the sensitivity to TGF-??-induced apoptosis, Nature Cell Biology, vol.6, issue.4, pp.366-372, 2004. ,
DOI : 10.1038/ncb1117
Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines, Journal of Biological Chemistry, vol.274, issue.31, pp.27421528-21532, 1999. ,
DOI : 10.1074/jbc.274.31.21528
AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon, Clin Cancer Res, vol.7, issue.8, pp.2475-2479, 2001. ,
(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells, Cancer Res, issue.15, pp.27-634322, 2003. ,
Responsiveness to PI3K and MEK Inhibitors in Breast Cancer. Use of a 3D Culture System to Study Pathways Related to Hormone Independence in Mice, PLoS ONE, vol.70, issue.5, p.10786, 2010. ,
DOI : 10.1371/journal.pone.0010786.g008
The turnover of estrogen receptor ?? by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy, Biochemical Pharmacology, vol.82, issue.2, pp.122-130, 2011. ,
DOI : 10.1016/j.bcp.2011.03.031
Transient inhibition of protein synthesis induces expression of proto-oncogenes and stimulates resting cells to enter the cell cycle, Cell Proliferation, vol.25, issue.12, pp.28631-644, 1995. ,
DOI : 10.1038/340064a0
p70 S6 Kinase-mediated Protein Synthesis Is a Critical Step for Vascular Endothelial Cell Proliferation, Journal of Biological Chemistry, vol.274, issue.38, pp.7026776-26782, 1999. ,
DOI : 10.1074/jbc.274.38.26776
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization, Genes & Development, vol.12, issue.22, pp.3499-3511, 1998. ,
DOI : 10.1101/gad.12.22.3499
Stable luciferase transfected cells for studying steroid receptor biological activity, Journal of Bioluminescence and Chemiluminescence, vol.5, issue.3, pp.201-209, 1994. ,
DOI : 10.1002/bio.1170090314
Altered Target Gene Regulation Controlled by Estrogen Receptor-?? Concentration, Molecular Endocrinology, vol.20, issue.2, pp.291-301, 2006. ,
DOI : 10.1210/me.2005-0288
Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element, Proceedings of the National Academy of Sciences, vol.96, issue.20, pp.11217-11222, 1999. ,
DOI : 10.1073/pnas.96.20.11217
Transcriptional regulation of the cyclin D1 gene at a glance, Journal of Cell Science, vol.121, issue.23, pp.3853-3857, 2008. ,
DOI : 10.1242/jcs.039131
The Cyclin-dependent Kinase Inhibitor p21CIP/WAF Is a Positive Regulator of Insulin-like Growth Factor I-induced Cell Proliferation in MCF-7 Human Breast Cancer Cells, Journal of Biological Chemistry, vol.278, issue.39, pp.27837256-37264, 2003. ,
DOI : 10.1074/jbc.M302355200
The IGF Pathway Regulates ER?? through a S6K1-Dependent Mechanism in Breast Cancer Cells, Molecular Endocrinology, vol.25, issue.3, pp.516-528, 2011. ,
DOI : 10.1210/me.2010-0373
Akt2 Inhibition Enables the Forkhead Transcription Factor FoxO3a To Have a Repressive Role in Estrogen Receptor ?? Transcriptional Activity in Breast Cancer Cells, Molecular and Cellular Biology, vol.30, issue.3, pp.857-870, 2010. ,
DOI : 10.1128/MCB.00824-09
Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes, Breast Cancer Research, vol.19, issue.Suppl 1, p.52, 2011. ,
DOI : 10.1093/bioinformatics/btg345
Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1, Molecular and Cellular Endocrinology, vol.229, issue.1-2, pp.161-173, 2005. ,
DOI : 10.1016/j.mce.2004.08.002
Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells, Journal of Endocrinology, vol.152, issue.1, pp.39-47, 1997. ,
DOI : 10.1677/joe.0.1520039
Aldaz CM: Effects of estrogen on global gene expression: identification of novel targets of estrogen action, Cancer Res, issue.21, pp.605977-5983, 2000. ,
Profiling of Estrogen Up- and Down-Regulated Gene Expression in Human Breast Cancer Cells: Insights into Gene Networks and Pathways Underlying Estrogenic Control of Proliferation and Cell Phenotype, Endocrinology, vol.144, issue.10, pp.1444562-4574, 2003. ,
DOI : 10.1210/en.2003-0567
RNA Interference-Mediated Depletion of Phosphoinositide 3-Kinase Activates Forkhead Box Class O Transcription Factors and Induces Cell Cycle Arrest and Apoptosis in Breast Carcinoma Cells, Cancer Research, vol.66, issue.2, pp.1062-1069, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-1018
A brief introduction to FOXOlogy, Oncogene, vol.14, issue.16, pp.2258-2262, 2008. ,
DOI : 10.1074/jbc.M106091200
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis, Breast Cancer Research, vol.10, issue.1, p.21, 2008. ,
DOI : 10.1186/bcr1872
Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin, Breast Cancer Res BCR, vol.2010, issue.123, p.32 ,
New Strategies in Estrogen Receptor-Positive Breast Cancer, Clinical Cancer Research, vol.16, issue.7, pp.1979-1987 ,
DOI : 10.1158/1078-0432.CCR-09-1823
Igf1r as a therapeutic target in a mouse model of basal-like breast cancer, Proceedings of the National Academy of Sciences, vol.106, issue.7, pp.2359-2364, 2009. ,
DOI : 10.1073/pnas.0810221106
Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells, BMC Cancer, vol.106, issue.7, p.291, 2012. ,
DOI : 10.1073/pnas.0810221106
URL : https://hal.archives-ouvertes.fr/inserm-00743408